Mr. Speaker, as outlined in the notice of intent, found at https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/notice-intent-address-risks-youth-appeal-access-nicotine-replacement-therapies.html and published by the department on March 20, 2024, Health Canada is considering legislative and regulatory mechanisms to address access and potential youth appeal of nicotine replacement therapies, or NRTs. New requirements, such as but not limited to specific requirements for labelling and packaging, as well as restrictions related to colours, flavours, advertising and place of sale, are being considered.
Health Canada is considering many sources of input as it continues to develop a proposed path forward, such as, for example, the publicly available information below. Please note that information on sources of input related to regulatory mechanisms will be published as part of a regulatory impact analysis statement along with any regulatory measures in the Canada Gazette, where appropriate.
Here are some examples of publicly available information: “Canada Gazette, Part 1, Volume 155, Number 25: Order Amending Schedules 2 and 3 to the Tobacco and Vaping Products Act (Flavours)”, at https://gazette.gc.ca/rp-pr/p1/2021/2021-06-19/html/reg2-eng.html; and the “Canadian Tobacco and Nicotine Survey (CTNS): summary of results for 2022”, at https://www.canada.ca/en/health-canada/services/canadian-tobacco-nicotine-survey/2022-summary.html.